{"id":430,"date":"2025-11-26T01:31:40","date_gmt":"2025-11-25T18:31:40","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/"},"modified":"2025-11-26T01:31:40","modified_gmt":"2025-11-25T18:31:40","slug":"fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/","title":{"rendered":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember"},"content":{"rendered":"<div id=\"block-content\">\n<p class=\"\">FDA akan mengadakan lokakarya publik satu hari, secara langsung dan virtual, \u201cMeningkatkan Hasil Anafilaksis: Pendekatan untuk Meningkatkan Akses terhadap <astro-island uid=\"AOqb3\" prefix=\"r62\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;306d5a5f0b60&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Epinephrine&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;52e8d4a9c167&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,false),&quot;href&quot;:(0,&quot;https:\/\/www.pharmtech.com\/view\/pharmtech-weekly-roundup-week-of-september-8-2025&quot;),&quot;nofollow&quot;:(0,true)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;52e8d4a9c167&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Epinefrin<!--astro:end--><\/astro-island>pada hari Selasa, 16 Desember 2025 (1) Lokakarya ini diadakan bersama dengan Institut Kebijakan Publik Margolis Universitas Duke.<\/p>\n<p class=\"\">Pengumuman lokakarya tersebut menguraikan tujuannya: untuk memulai diskusi tentang perluasan aksesibilitas, dan penggunaan, epinefrin untuk mengurangi morbiditas dan mortalitas terkait anafilaksis, termasuk di lingkungan komunitas (1).<\/p>\n<p class=\"\">\u201cMeskipun peran penting epinefrin dalam mencegah kematian akibat anafilaksis, potensi hambatan membatasi akses dan penggunaan obat penyelamat jiwa ini,\u201d kata pengumuman tersebut (1). \u201cPasien yang diberi resep epinefrin mungkin tidak tersedia selama anafilaksis, mungkin memilih untuk tidak menggunakannya karena kesenjangan pengetahuan, ketakutan, stigma, kesalahan persepsi, atau ketidaknyamanan, atau mungkin menggunakannya secara tidak benar, sehingga mengakibatkan dosis yang tidak memadai.\u201d<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Apa inovasi terkini dalam menargetkan anafilaksis?<\/strong><\/h2>\n<p class=\"\">Dalam 18 bulan terakhir, badan pengawas telah memperluas akses terhadap pengobatan epinefrin yang berpotensi menyelamatkan nyawa, khususnya dalam formulasi semprotan hidung yang dikembangkan oleh perusahaan yang berbasis di San Diego. <astro-island uid=\"Z1VeMuc\" prefix=\"r63\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;eedf3f09402e&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;ARS Pharmaceuticals.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;0b6a5ba7c00f&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/ars-pharma.com\/&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;0b6a5ba7c00f&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Farmasi ARS.<!--astro:end--><\/astro-island><\/p>\n<p class=\"\">Produk ARS, yang dikenal sebagai Neffy di Amerika Serikat dan dikomersialkan di luar AS, Australia, Selandia Baru, Jepang, dan Tiongkok oleh <astro-island uid=\"2sLvM6\" prefix=\"r64\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;caedf28f0a72&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;ALK&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;a7202d510324&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.alk.net\/&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;a7202d510324&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">ALK<!--astro:end--><\/astro-island>    sebagai EURneffy, dulu <astro-island uid=\"1WhxL3\" prefix=\"r65\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;2161c339dc61&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;recommended for approval&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;cc88482f037e&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.pharmtech.com\/view\/first-nasal-adrenaline-spray-among-ema-approvals-in-june&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;cc88482f037e&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">direkomendasikan untuk disetujui<!--astro:end--><\/astro-island>    oleh Komite Produk Obat untuk Penggunaan Manusia Badan Obat Eropa pada Juni 2024, <astro-island uid=\"Z1CnGKk\" prefix=\"r66\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;302a50469d96&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;approved by FDA&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;342c53403ecc&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.pharmtech.com\/view\/uk-anaphylaxis-nasal-spray-approval-helps-reshape-emergency-allergy-treatment&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;342c53403ecc&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">disetujui oleh FDA<!--astro:end--><\/astro-island>    pada bulan Agustus 2024, dan disetujui oleh Badan Pengatur Produk Obat dan Kesehatan Inggris pada bulan Juli 2025 (2\u20134).<\/p>\n<p class=\"\">ALK <astro-island uid=\"ZigyLf\" prefix=\"r67\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;c522c858b04c&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;later announced,&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;3333546f8849&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.pharmtech.com\/view\/how-alk-uk-approved-nasal-spray-changes-rd-model-acute-emergency-treatment&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;3333546f8849&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">kemudian diumumkan,<!--astro:end--><\/astro-island>    pada tanggal 20 Oktober 2025, EURneffy akan tersedia untuk resep oleh profesional kesehatan di Inggris (5).<\/p>\n<p><astro-island uid=\"ZhKUVp\" prefix=\"r74\" component-url=\"\/_astro\/figure.ROEGDD4M.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_key&quot;:(0,&quot;c85c2f7840aa&quot;),&quot;_type&quot;:(0,&quot;figure&quot;),&quot;alignment&quot;:(0,&quot;center&quot;),&quot;asset&quot;:(0,{&quot;_ref&quot;:(0,&quot;image-e25b084dd897abfea1cec11b55385d10fb71fc3a-2152x467-png&quot;),&quot;_type&quot;:(0,&quot;reference&quot;)}),&quot;disableLightBox&quot;:(0,true),&quot;imageFit&quot;:(0,&quot;crop&quot;),&quot;medias&quot;:(0,null),&quot;uploadAudio&quot;:(0,null),&quot;upload_doc&quot;:(0,null),&quot;widthP&quot;:(0,75)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;FigurePlugin&quot;,&quot;value&quot;:true}\"\/><\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Bagaimana hal ini dapat membantu mereka yang mengalami reaksi alergi tipe 1?<\/strong><\/h2>\n<p class=\"\">Pada saat persetujuan FDA pada Agustus 2024, Richard Lowenthal, salah satu pendiri, presiden, dan CEO ARS Pharmaceuticals, mengomentari potensi dampak ketersediaan obat anafilaksis dalam bentuk semprotan hidung.<\/p>\n<p class=\"\">\u201cPersetujuan ini menandai momen penting dalam mengatasi kebutuhan medis yang belum terpenuhi bagi orang-orang dengan alergi tipe 1\u2014sebuah alternatif pengobatan yang menghindari kebutuhan untuk menyuntikkan epinefrin dengan jarum, yang dapat menimbulkan kecemasan dan ketakutan bagi banyak orang,\u201d kata Lowenthal (3).<\/p>\n<p class=\"\">Menyusul persetujuan Inggris pada bulan Oktober 2025 atas penggunaan resep EURneffy, Amena Warner, Kepala Layanan Klinis di Allergy UK, mengutarakan tema yang sama.<\/p>\n<p class=\"\">\u201cBeberapa anak muda enggan membawa perangkat auto-injector karena dianggap berukuran besar,\u201d kata Warner (5). \u201cHal ini mengkhawatirkan bagi para profesional kesehatan dan orang tua, karena meningkatkan risiko penundaan pengobatan yang berpotensi menyelamatkan nyawa.\u201d<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Bagaimana masyarakat dapat berpartisipasi dalam lokakarya ini?<\/strong><\/h2>\n<p class=\"\">Komentar dari masyarakat, yang disampaikan baik dalam bentuk elektronik maupun tertulis, akan diterima hingga satu bulan setelah lokakarya, hingga 16 Januari 2026 (1). Formulir pengiriman online tersedia <astro-island uid=\"Z1MFAVt\" prefix=\"r68\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;6469442eb95a&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;through the &quot;)}),(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;e06a0f808b6a&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Federal Register&quot;)}))),&quot;markDef&quot;:(0),&quot;markType&quot;:(0,&quot;em&quot;),&quot;markKey&quot;:(0,&quot;em&quot;)}),(0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot; website&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;aa88ab3172af&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.federalregister.gov\/documents\/2025\/11\/24\/2025-20658\/improving-anaphylaxis-outcomes-approaches-for-enhancing-access-to-epinephrine-public-workshop#open-comment&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;aa88ab3172af&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">melalui <em>Daftar Federal<\/em> situs web<!--astro:end--><\/astro-island>. Periode permintaan untuk melakukan presentasi lisan pada lokakarya ditutup pada 21 November; peserta akan dipilih dan diberitahukan paling lambat tanggal 1 Desember, dan semua materi presentasi harus sudah diserahkan paling lambat tanggal 11 Desember.<\/p>\n<p class=\"\">Komponen lokakarya secara tatap muka akan diadakan di Duke in DC Office, 1201 Pennsylvania Ave. NW, Suite 500, Washington, DC, mulai pukul 09.00 hingga 16.30 pada 16 Desember 2025 (1).<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Referensi<\/strong><\/h2>\n<p class=\"\">1. FDA, <astro-island uid=\"1udRTC\" prefix=\"r69\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;d8bc1fae7170&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;\u201cImproving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine,\u201d&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;71f04c753426&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.federalregister.gov\/documents\/2025\/11\/24\/2025-20658\/improving-anaphylaxis-outcomes-approaches-for-enhancing-access-to-epinephrine-public-workshop&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;71f04c753426&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">\u201cMeningkatkan Hasil Anafilaksis: Pendekatan untuk Meningkatkan Akses terhadap Epinefrin,\u201d<!--astro:end--><\/astro-island>    Pemberitahuan Lokakarya Publik\u2014Permintaan Komentar, <em>Daftar Federal<\/em>90 FR 52958, 52958\u201352960.<br \/>2. Ibu. <astro-island uid=\"ZXR2CO\" prefix=\"r70\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;4d3664caf4c3&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;First Nasal Adrenaline Spray for Emergency Treatment Against Allergic Reactions.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;fe9ab9b8cd28&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.ema.europa.eu\/en\/news\/first-nasal-adrenaline-spray-emergency-treatment-against-allergic-reactions&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;fe9ab9b8cd28&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Semprotan Adrenalin Hidung Pertama untuk Perawatan Darurat Melawan Reaksi Alergi.<!--astro:end--><\/astro-island>    Siaran Pers. 28 Juni 2024.<br \/>3. FDA. <astro-island uid=\"5l6YO\" prefix=\"r71\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;669a134c4712&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;FDA Approves First Nasal Spray for Treatment of Anaphylaxis.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;33776d416874&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nasal-spray-treatment-anaphylaxis&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;33776d416874&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">FDA Menyetujui Semprotan Hidung Pertama untuk Pengobatan Anafilaksis.<!--astro:end--><\/astro-island>    Siaran Pers. 9 Agustus 2024.<br \/>4.ALK. <astro-island uid=\"Z1TGFxx\" prefix=\"r72\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;af3d5d9bdd40&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;EURneffy Approved as the First Needle-Free Anaphylaxis Treatment of Adults and Children in the UK.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;63af79c8763d&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/ir.alk.net\/news-releases\/news-release-details\/eurneffyr-approved-first-needle-free-anaphylaxis-treatment&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;63af79c8763d&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">EURneffy Disetujui sebagai Pengobatan Anafilaksis Tanpa Jarum Pertama untuk Orang Dewasa dan Anak-anak di Inggris.<!--astro:end--><\/astro-island>    Siaran Pers. 18 Juli 2025.<br \/>5. Alergi Inggris. <astro-island uid=\"Z6SVGx\" prefix=\"r73\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;5820278962b4&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Allergy UK Welcomes Needle-Free Emergency Adrenaline Treatment for Anaphylaxis.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;a7aa05cb8d22&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.allergyuk.org\/news\/eurneffy\/&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;a7aa05cb8d22&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Allergy UK Menyambut Baik Perawatan Adrenalin Darurat Tanpa Jarum untuk Anafilaksis.<!--astro:end--><\/astro-island>    Siaran Pers. 20 Oktober 2025.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FDA akan mengadakan lokakarya publik satu hari, secara langsung dan virtual, \u201cMeningkatkan Hasil Anafilaksis: Pendekatan untuk Meningkatkan Akses terhadap Epinefrinpada hari Selasa, 16 Desember 2025 (1) Lokakarya ini diadakan bersama dengan Institut Kebijakan Publik Margolis Universitas Duke. Pengumuman lokakarya tersebut menguraikan tujuannya: untuk memulai diskusi tentang perluasan aksesibilitas, dan penggunaan, epinefrin untuk mengurangi morbiditas dan [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-430","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"FDA akan mengadakan lokakarya publik satu hari, secara langsung dan virtual, \u201cMeningkatkan Hasil Anafilaksis: Pendekatan untuk Meningkatkan Akses terhadap Epinefrinpada hari Selasa, 16 Desember 2025 (1) Lokakarya ini diadakan bersama dengan Institut Kebijakan Publik Margolis Universitas Duke. Pengumuman lokakarya tersebut menguraikan tujuannya: untuk memulai diskusi tentang perluasan aksesibilitas, dan penggunaan, epinefrin untuk mengurangi morbiditas dan [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T18:31:40+00:00\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember\",\"datePublished\":\"2025-11-25T18:31:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\"},\"wordCount\":540,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\",\"name\":\"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg\",\"datePublished\":\"2025-11-25T18:31:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg\",\"width\":2560,\"height\":1706},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/","og_locale":"id_ID","og_type":"article","og_title":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT","og_description":"FDA akan mengadakan lokakarya publik satu hari, secara langsung dan virtual, \u201cMeningkatkan Hasil Anafilaksis: Pendekatan untuk Meningkatkan Akses terhadap Epinefrinpada hari Selasa, 16 Desember 2025 (1) Lokakarya ini diadakan bersama dengan Institut Kebijakan Publik Margolis Universitas Duke. Pengumuman lokakarya tersebut menguraikan tujuannya: untuk memulai diskusi tentang perluasan aksesibilitas, dan penggunaan, epinefrin untuk mengurangi morbiditas dan [&hellip;]","og_url":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2025-11-25T18:31:40+00:00","author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"3 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember","datePublished":"2025-11-25T18:31:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/"},"wordCount":540,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg","articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/","url":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/","name":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg","datePublished":"2025-11-25T18:31:40+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#primaryimage","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/11\/8c74fc8d63f22051055081b1177a3ddc350004e9-5800x3866-scaled.jpg","width":2560,"height":1706},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/26\/fda-lokakarya-perencanaan-akses-epinefrin-universitas-duke-untuk-bulan-desember\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"FDA, Lokakarya Perencanaan Akses Epinefrin Universitas Duke untuk bulan Desember"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=430"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/430\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media\/431"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}